Shukaib Arslan, MD

• Acute Myeloid Leukemia

Dr. Arslan’s clinical and research interests center on donor identification, therapies for post-transplant relapse of acute leukemia, treatment of graft versus host disease (GVHD) as well as outcomes of alternative donor transplant. Dr. Arslan is currently the principal investigator of a number of clinical trials including cellular therapy and therapies for GVHD. One of these studies is evaluating the role of multi-tumor antigen specific T-cells for prevention and treatment of relapse of acute myeloid leukemia in post-transplant setting. Other studies involve use of novel agents for prevention and treatment of GVHD. Dr. Arslan is participating as co-investigator in several studies involving novel therapies for acute leukemia in upfront and relapsed setting. His research also focuses on treatment of complications from ABO incompatible allogeneic hematopoietic cell transplantation such as pure red cell aplasia.